Most Eligible Patients With Diabetic Kidney Disease Not Receiving SGLT2 Inhibitor Prescriptions
May 17th 2021Two-thirds of patients with diabetic kidney disease who are eligible for treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitors are not being prescribed them, a new study shows.
Read More
Analysis Looks at SGLT2 Inhibitors Across Diabetes, Heart Failure, CKD
May 14th 2021Sodium-glucose transporter 2 (SGLT2) inhibitors decrease the risk of acute kidney injury and severe hypoglycemia for those with diabetes, heart failure, and chronic kidney disease (CKD) but increase the risk of diabetic ketoacidosis.
Read More
What Are the Most Common Reasons for Hospital Admissions for Patients With Diabetes?
May 8th 2021Soft tissue and bone infections, urinary tract infections, stroke, and electrolyte disorder top the reasons why patients with diabetes are admitted to the hospital at greater frequency and cost compared with patients without the disease, according to a new study.
Read More
Dropping Race From eGFR Doubles Estimated Prevalence of CKD in Black Populations
May 6th 2021The study results were released as nephrologists and others are awaiting the findings of a joint task force of 2 national kidney organizations looking at alternative approaches to estimating glomerular filtration rate.
Read More